Drug · DIN 02478382
TRUXIMA
10 MG/ML SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 24, 2025; first marketed December 11, 2019.
- Drug Identification Number (DIN)
- 02478382
- Company (DIN owner)
- Celltrion Inc.Incheon, Korea, Republic Of
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Rituximab L01FA01
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RITUXIMAB | 100 MG | 10 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 22, 2024: NOC 33881New Drug Submission (NDS) · Administrative ¿ Merger/Buy-out
- April 4, 2019: NOC 22041New Drug Submission (NDS)
Other DINs named TRUXIMA
- DIN 02478390 · Marketed